Administration of BDNF in the ventral tegmental area produces a switch from a nicotine‐non‐dependent D1R‐mediated motivational state to a nicotine‐dependent‐like D2R‐mediated motivational state

Taryn E. Grieder; Mandy Yee; Hector Vargas‐PerezGeith Maal‐BaredSusan GeorgeRyan Ting‐A‐KeeOlivier GeorgeDerek Kooy

首页> 外文期刊>The European journal of neuroscience. >Administration of BDNF in the ventral tegmental area produces a switch from a nicotine‐non‐dependent D1R‐mediated motivational state to a nicotine‐dependent‐like D2R‐mediated motivational state

【24h】

Administration of BDNF in the ventral tegmental area produces a switch from a nicotine‐non‐dependent D1R‐mediated motivational state to a nicotine‐dependent‐like D2R‐mediated motivational state

机译：Administration of BDNF in the ventral tegmental area produces a switch from a nicotine‐non‐dependent D1R‐mediated motivational state to a nicotine‐dependent‐like D2R‐mediated motivational state

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相关主题

摘要

Abstract Brain‐derived neurotrophic factor (BDNF) has been implicated in the transition from a non‐dependent motivational state to a drug‐dependent and drug‐withdrawn motivational state. Chronic nicotine can increase BDNF in the rodent brain and is associated with smoking severity in humans; however, it is unknown whether this increased BDNF is linked functionally to the switch from a nicotine‐non‐dependent to a nicotine‐dependent state. We used a place conditioning paradigm to measure the conditioned responses to nicotine, showing that a dose of acute nicotine that non‐dependent male mice find aversive is found rewarding in chronic nicotine‐treated mice experiencing withdrawal. A single BDNF injection in the ventral tegmental area (in the absence of chronic nicotine treatment) caused mice to behave as if they were nicotine dependent and in withdrawal, switching the neurobiological substrate mediating the conditioned motivational effects from dopamine D1 receptors to D2 receptors. Quantification of gene expression of BDNF and its receptor, tropomyosin‐receptor‐kinase B (TrkB), revealed an increase in TrkB mRNA but not BDNF mRNA in the VTA in nicotine‐dependent and nicotine‐withdrawn mice. These results suggest that BDNF signalling in the VTA is a critical neurobiological substrate for the transition to nicotine dependence. The modulation of BDNF signalling may be a promising new pharmacological avenue for the treatment of addictive behaviour.

著录项

来源
《The European journal of neuroscience.》 |2022年第3期|714-724|共11页
作者
Taryn E. Grieder; Mandy Yee; Hector Vargas‐PerezGeith Maal‐BaredSusan GeorgeRyan Ting‐A‐KeeOlivier GeorgeDerek Kooy;
展开▼
作者单位

Department of Molecular Genetics and Institute of Medical Science,University of Toronto;

The Nierika Intercultural Medicine Institute;

Department of Psychiatry,UCSD School of Medicine;

展开▼
收录信息
原文格式 PDF
正文语种英语
中图分类神经病学与精神病学;
关键词

Administration of BDNF in the ventral tegmental area produces a switch from a nicotine‐non‐dependent D1R‐mediated motivational state to a nicotine‐dependent‐like D2R‐mediated motivational state

摘要

著录项

相关主题

期刊订阅